Ozempic weight loss injections in Broadstairs: the full picture

You've heard about Ozempic, but the prescription you'd actually receive looks different

Picture this: a friend in Broadstairs lost noticeable weight and mentioned Ozempic. You searched online and found clinics offering it. Then your GP or an online form told you it wasn't available for weight loss. Confusing, yes. But the logic is straightforward once you understand the licensing.

Ozempic and Wegovy both contain semaglutide, a GLP-1 receptor agonist that slows gastric emptying and reduces appetite. The difference is dose and licence. Ozempic delivers up to 1mg weekly and is authorised by the MHRA purely for type 2 diabetes control. Wegovy delivers up to 2.4mg weekly (and, since April 2026, up to 7.2mg via a dedicated single-dose pen) and holds a separate UK licence for weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. A prescriber working within UK law would not routinely reach for Ozempic when a patient's goal is weight loss, Wegovy is the appropriate, licensed route, and that's the medicine you'd be assessed for. If you're based in the capital and want to understand how this works in practice, our page on Ozempic weight loss injections in London covers the licensed landscape and what a clinical assessment involves. You can read more about how semaglutide is used in this context on our overview of Ozempic and weight loss injections.

The NHS's semaglutide medicines page sets this out clearly, listing Ozempic and Wegovy as distinct products with distinct indications. Worth reading if you want the regulator-endorsed summary in plain language.

What a Broadstairs resident can realistically access, and through which route

A question our prescribers hear most weeks is whether someone can just ask their GP to prescribe Ozempic for weight loss instead. The honest answer is: it's unlikely to happen through a standard GP appointment, because it's off-label for weight management and NHS commissioning doesn't support it in that role. Wegovy on the NHS is available through specialist weight management services, but waiting lists in many areas of Kent are long, and the eligibility criteria are strict, NICE's guidance (TA875) requires a BMI of 35 or above alongside at least one weight-related comorbidity, and treatment within a multidisciplinary specialist service.

Mounjaro, the tirzepatide injection made by Eli Lilly, operates under a different NHS pathway (NICE TA1026, updated September 2025). NHS access for Mounjaro is currently being phased in: from June 2025, adults with a BMI of 40 or above and four or more qualifying health conditions became eligible; a second cohort with BMI 35–39.9 was added in June 2026. That still leaves a large number of people in Broadstairs and across East Kent who meet the private licence criteria but not the NHS threshold.

For those people, a regulated private pharmacy is the legal alternative. Our Wegovy treatment page explains how the private route works and what clinical checks are involved. If you're also curious how other people in your region access semaglutide treatment privately, our page on finding weight loss injections near you covers the practical considerations.

Safety first: what to check before you commit to any online clinic

Fake semaglutide pens are a serious and growing problem. The MHRA has seized large quantities of counterfeit weight-loss pens across the UK, some contained insulin rather than semaglutide, creating a dangerous hypoglycaemia risk in people without diabetes. The MHRA's Yellow Card scheme lets you report both suspected side effects and any seller you believe may be supplying counterfeit or unlicensed medicines.

The red flags are consistent: sellers offering semaglutide injections without requiring a prescriber assessment, prices dramatically below the market rate, and social-media sellers with no verifiable pharmacy registration. Any legitimate UK online pharmacy can be checked on the GPhC register, the registration number should be displayed and clickable. If it isn't, that's a material warning sign.

Cost is a real consideration and we don't dismiss it. Our page on Wegovy pricing in the UK breaks down what's typically included (and often excluded) from headline prices you'll see advertised. For a prescription medicine, the cheapest option is rarely the safest question to ask.

Side effects from semaglutide are well documented and manageable for most people, but they deserve honest attention before you start. Our dedicated page on side effects of weight loss injections covers what to expect and when to seek medical help.

The medicines actually licensed for weight management in the UK

If weight management treatment is what you're looking for, there are two injectable options with full MHRA weight-loss licences: Wegovy (semaglutide) and Mounjaro (tirzepatide). Tirzepatide activates both GLP-1 and GIP receptors, the only dual-agonist weight-loss medicine currently licensed in the UK. In SURMOUNT-1, a large clinical trial published in the New England Journal of Medicine, participants on the highest tirzepatide dose lost around 20–21% of their body weight on average over 72 weeks. Wegovy at 2.4mg showed around 15% average loss in its pivotal STEP 1 trial, with the newer 7.2mg dose producing approximately 20.7% in more recent studies.

Both require a prescriber to assess your eligibility. Neither can be bought legitimately without that clinical step, not in Broadstairs, not anywhere in the UK. Our weight-loss treatment overview sets out how both medicines compare and what the assessment process looks like. If you'd like to explore which might be appropriate for you, the first step is a free consultation with one of our GPhC-registered prescribers, a real clinician who reviews your answers the same day. You can start that process at our treatment consultation page, or read about our clinical team's background on the clinical team profile.